To access this work you must either be on the Smith College campus OR have valid Smith login credentials.

On Campus users: To access this work if you are on campus please Select the Download button.

Off Campus users: To access this work from off campus, please select the Off-Campus button and enter your Smith username and password when prompted.

Non-Smith users: You may request this item through Interlibrary Loan at your own library.

Publication Date

2025-5

First Advisor

Sarah J. Moore

Document Type

Honors Project

Degree Name

Bachelor of Arts

Department

Biochemistry

Keywords

intracellular trafficking, apoptosis-inducing factor, Fn3 3.4.4-flag protein, mesothelin, cancer therapeutics

Abstract

Cancer is a leading cause of disease-related mortality worldwide. Unlike conventional chemotherapy and surgical debulking, targeted therapy utilizes small molecule drugs or monoclonal antibodies to specifically inhibit signaling pathways that drive cancer cell growth. This approach offers a more effective treatment with fewer side effects, ultimately improving overall survival (OS). Mesothelin (MSLN) is a tumor associated antigen overexpressed on the surface of many cancer types, making it a promising biomarker for therapeutic development. The Moore lab engineered multiple variants of a small protein scaffold based on fibronectin type III (Fn3) that selectively binds to MSLN with high affinity. Specifically, we have engineered MSLN-binding Fn3 3.4.4 that could either induce apoptosis or can be coupled with chemotherapy drugs to develop protein-drug conjugates (PDC) as targeted treatments. Even though Fn3 3.4.4 has been developed as a potential targeted therapeutic, its efficacy and apoptosis-mediated signaling are not yet fully understood. Therefore, this thesis aims to further characterize Fn3 3.4.4 in MSLN-expressing cells by integrating engineering and biological principles. From an engineering perspective, intracellular trafficking has been measured towards the goal to develop bio-kinetic transport models and optimize the design of protein-drug conjugates (PDCs). Confocal studies with immunofluorescence have been conducted to analyze the colocalization of Fn3 within various cellular compartments such as endosomes and lysosomes. 6 From a biological perspective, this thesis reports the development of methods to understand the signaling pathways induced in MSLN-expressing cancer cells by Fn3 treatment. More specifically, the potential for translocation of apoptosis-inducing factor (AIF) from the mitochondria to the nucleus has been studied as a possible caspase-independent apoptosis pathway. Methods reported include measuring AIF activation with immunofluorescence and cellular fraction western blot studies, providing insight for future development of MSLN-targeting therapeutic strategies.

Rights

©2025 Wenjun Zhao. Access limited to the Smith College community and other researchers while on campus. Smith College community members also may access from off-campus using a Smith College log-in. Other off-campus researchers may request a copy through Interlibrary Loan for personal use.

Language

English

Comments

78 pages: color illustrations, charts. Includes bibliographical references (pages 69-73).

Download

Smith Only:
Off Campus Download

Share

COinS